Top Upgrades
- Analysts at B. Riley upgraded Zumiez Inc. ZUMZ from Neutral to Buy. Zumiez shares gained 13.64 percent to $15.00 in pre-market trading.
- Credit Suisse upgraded Ralph Lauren Corp RL from Neutral to Outperform. Ralph Lauren shares dropped 2 percent to close at $88.74 on Thursday.
- Bank of America upgraded Brighthouse Financial Inc BHF from Underperform to Neutral. Brighthouse Financial shares declined 0.34 percent to close at $53.00 on Thursday.
- Analysts at BTIG Research upgraded Mid-America Apartment Communities Inc MAA from Neutral to Buy. Mid-America Apartment shares rose 0.62 percent to close at $107.03 on Thursday.
- Analysts at William Blair upgraded Huron Consulting Group HURN from Market Perform to Outperform. Huron Consulting shares rose 0.65 percent to close at $30.95 on Thursday.
- Leerink Swann upgraded Teleflex Incorporated TFX from Market Perform to Outperform. Teleflex shares rose 0.03 percent to $227.20 in pre-market trading.
- Jefferies upgraded NewLink Genetics Corp NLNK from Hold to Buy. NewLink Genetics shares gained 2.94 percent to $14.00 in pre-market trading.
- Baird upgraded Zions Bancorp ZION from Underperform to Neutral. Zions Bancorp shares fell 3 percent to close at $41.33 on Thursday.
- Canaccord Genuity upgraded RLJ Lodging Trust RLJ from Hold to Buy. RLJ Lodging shares declined 0.78 percent to close at $20.39 on Thursday.
- Credit Suisse upgraded Navient Corp NAVI from Neutral to Outperform. Navient shares fell 4.78 percent to close at $13.14 on Thursday.
Top Downgrades
- Morgan Stanley downgraded Capital One Financial Corp. COF from Overweight to Equal-Weight. Capital One Financial shares fell 1.56 percent to close at $78.23 on Thursday.
- Credit Suisse downgraded PepsiCo, Inc. PEP from Outperform to Neutral. PepsiCo shares fell 0.48 percent to $116.43 in pre-market trading.
- Analysts at KeyBanc downgraded Catalent Inc CTLT from Overweight to Sector Weight. Catalent shares fell 1.28 percent to $40.82 in pre-market trading.
- Baird downgraded Equity Lifestyle Properties, Inc. ELS from Outperform to Neutral. Equity Lifestyle shares rose 0.10 percent to close at $90.41 on Thursday.
- Citigroup downgraded Calpine Corporation CPN from Buy to Neutral. Calpine shares fell 0.41 percent to $14.60 in pre-market trading.
- Goldman Sachs downgraded Rice Energy Inc RICE from Buy to Neutral. Rice Energy shares fell 1.23 percent to close at $27.34 on Thursday.
- Analysts at Cowen & Co. downgraded Chipotle Mexican Grill, Inc. CMG from Market Perform to Underperform. Chipotle shares fell 2.13 percent to $310.50 in pre-market trading.
- Bank of America downgraded Tintri Inc TNTR from Buy to Neutral. Tintri shares tumbled 21.41 percent to $5.25 in pre-market trading.
- Morgan Stanley downgraded Synchrony Financial SYF from Overweight to Equal-Weight. Synchrony Finl shares fell 1.45 percent to $28.64 in pre-market trading.
- Goldman Sachs downgraded Range Resources Corp. RRC from Buy to Neutral. Range Resources shares fell 0.56 percent to $17.81 in pre-market trading.
Top Initiations
- Analysts at Goldman Sachs initiated coverage on Electronic Arts Inc. EA with a Buy rating. The price target for Electronic Arts is set to $136. Electronic Arts shares closed at $118.93 on Thursday.
- Barclays initiated coverage on Intercontinental Exchange Inc ICE with an Overweight rating. The price target for Intercontinental Exchange is set to $72. Intercontinental Exchange shares closed at $64.30 on Thursday.
- Wedbush initiated coverage on CytomX Therapeutics Inc CTMX with an Outperform rating. The price target for CytomX Therapeutics is set to $26. CytomX Therapeutics shares closed at $16.97 on Thursday.
- Jefferies initiated coverage on LivaNova PLC LIVN with a Buy rating. The price target for LivaNova is set to $76. LivaNova shares closed at $63.20 on Thursday.
- Analysts at Goldman Sachs initiated coverage of Take Two Interactive Software Inc TTWO with a Buy rating. The price target for Take Two is set to $118. Take Two shares closed at $99.50 on Thursday.
- Analysts at Morgan Stanley initiated coverage on TherapeuticsMD Inc TXMD with an Equal-Weight rating. The price target for TherapeuticsMD is set to $6. TherapeuticsMD shares closed at $6.91 on Thursday.
- Analysts at KeyBanc initiated coverage on RealPage Inc RP with an Overweight rating. The price target for RealPage is set to $50. RealPage shares closed at $41.45 on Thursday.
- Barclays initiated coverage on BlackRock, Inc. BLK with an Overweight rating. The price target for BlackRock is set to $475. BlackRock shares closed at $414.25 on Thursday.
- Analysts at Argus initiated coverage on Anheuser Busch Inbev NV (ADR) BUD with a Buy rating. The price target for Anheuser Busch Inbev is set to $136. Anheuser Busch Inbev closed at $121.21 on Thursday.
- Barclays initiated coverage of Nasdaq Inc NDAQ with an Overweight rating. The price target for Nasdaq is set to $85. Nasdaq shares closed at $73.72 on Thursday.
Loading...
Loading...
BHFBrighthouse Financial Inc
$59.000.24%
Edge Rankings
Momentum
87.65
Growth
19.33
Quality
Not Available
Value
96.53
Price Trend
Short
Medium
Long
CMGChipotle Mexican Grill Inc
$54.002.31%
COFCapital One Financial Corp
$203.282.47%
CTMXCytomX Therapeutics Inc
$2.16-6.86%
EAElectronic Arts Inc
$155.983.60%
ELSEquity Lifestyle Properties Inc
$64.031.96%
HURNHuron Consulting Group Inc
$133.871.31%
LIVNLivaNova PLC
$45.570.13%
MAAMid-America Apartment Communities Inc
$150.161.08%
NAVINavient Corp
$13.630.89%
PEPPepsiCo Inc
$129.200.10%
RLRalph Lauren Corp
$270.552.42%
RLJRLJ Lodging Trust
$7.301.53%
RRCRange Resources Corp
$40.55-6.20%
SYFSynchrony Financial
$63.251.46%
TFXTeleflex Inc
$118.06-0.21%
TTWOTake-Two Interactive Software Inc
$242.651.80%
ZIONZions Bancorp NA
$49.471.83%
ZUMZZumiez Inc
$12.741.59%
BLKBlackRock Inc
$985.501.14%
BUDAnheuser-Busch InBev SA/NV
$71.480.41%
ICEIntercontinental Exchange Inc
$179.730.73%
NDAQNasdaq Inc
$86.500.47%
TXMDTherapeuticsMD Inc
$1.08-0.92%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in